Preeclampsia Clinical Trial
Official title:
Validation of a Protein Creatinine (PrCr) Dipstick Diagnostic Test for Proteinuria Screening in Antenatal Care Clinics in Ghana
This evaluation will aim to generate a body of evidence that will determine performance
characteristics of the current PrCr dipstick test and the feasibility of its use in target
ANC settings. Data will be used to inform further product development and/or support
development of an introduction framework, including the process and associated resources
needed for incorporation of the PrCr test into future larger-scale demonstration studies as
well as to support early product launch.
The objectives of the evaluation are as follows:
Primary objective: Assess the accuracy of the PrCr dipstick test for detection of proteinuria
in representative antenatal care settings in Ghana.
Exploratory objectives:
- Understand the feasibility of integrating the use of the PrCr test into ANC services in
Ghana.
- Explore the potential for improved ANC management of PE/E using the PrCr test in
intended ANC settings versus the current standard of care used for proteinuria
screening, protein-only determination via a low -cost urine dipstick test.
This cross-sectional diagnostic accuracy evaluation will employ mixed methods to assess the
performance of the PrCr dipstick test and to explore the operational feasibility of using
this test as an alternative to the current protein-only test. These methods include:
Assess the accuracy of the PrCr test for detection of proteinuria in a representative ANC
setting in Ghana.
• Detection of proteinuria using the PrCr dipstick test compared to the current standard of
care and laboratory reference assay used for confirming proteinuria. Patient samples will be
tested with multiple assays. The PrCr test and a protein-only dipstick (The Mission®
Urinalysis Reagent Strips (Urine), will be used at the point of care. Patient samples will be
transferred to KHRC laboratory using cold boxes (conditioned at 2oC - 8oC) and will be tested
using a laboratory reference assay.
Understand the feasibility of integrating the use of the PrCr test into ANC services.
- Pre- and post-evaluation of ANC staff training on use of the PrCr test
- Interviews with ANC staff
- Consultations with key district and national stakeholders.
Explore the potential for improved ANC management of PE/E using the PrCr test in the intended
ANC setting.
- Analysis of pregnancy outcomes (live or stillbirth) and review of referral records.
Actual outcomes along with referral practices and linkage to care based on the current
diagnostics will be compared to any potential changes in referral practices and linkage
to care based on prospective PrCr test results.
- Assessment of use of PrCr test with other clinical indicators and integration into
diagnostic algorithms. Prospective PrCr test results will be integrated into an existing
diagnostic algorithm to assess any potential changes in referral practices and linkage
to care.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03313024 -
Berlin-Brandenburg Pregnancy Cohort
|
||
| Active, not recruiting |
NCT04990141 -
Molecular Screening Method for Preeclampsia (PREMOM)
|
||
| Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
| Not yet recruiting |
NCT05999851 -
Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy
|
N/A | |
| Recruiting |
NCT02923206 -
Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis
|
N/A | |
| Not yet recruiting |
NCT02541110 -
Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler
|
N/A | |
| Terminated |
NCT02558023 -
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
|
Phase 3 | |
| Completed |
NCT02854501 -
Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Placentation Disorders
|
||
| Completed |
NCT02384226 -
User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
|
||
| Withdrawn |
NCT05016440 -
Lisinopril for Renal Protection in Postpartum Preeclamptic Women
|
N/A | |
| Completed |
NCT02554604 -
Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies
|
||
| Recruiting |
NCT02247297 -
Pancreatic Stone Protein (PSP) in Pregnant Women
|
||
| Recruiting |
NCT02337049 -
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
|
N/A | |
| Completed |
NCT02238704 -
Cornell University-Micronutrient Initiative Calcium Supplementation Study
|
N/A | |
| Withdrawn |
NCT01179542 -
The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR
|
N/A | |
| Completed |
NCT01195441 -
Prediction and Prevention of Preeclampsia by First Trimester Ultrasound
|
N/A | |
| Completed |
NCT00456118 -
Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies
|
||
| Recruiting |
NCT00117546 -
Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia
|
Phase 4 | |
| Completed |
NCT00787241 -
Platelet Count Trends in Pre-eclamptic Parturients
|
N/A | |
| Completed |
NCT04658966 -
Validation of the French Translation of a Self-questionnaire Looking for a History of Pre-eclampsia.
|